Pinned Tweet
Dive into something worth pondering. Cancer Cell’s November issue is out now: cell.com/cancer-cell/issue?p…
Online Now: Antibiotics counteracting tumor-promoting dysbiosis in colorectal cancer dlvr.it/TWMrnq
Online Now: Targeting F. nucleatum with metronidazole plus tislelizumab and fruquintinib in MSS colorectal cancer: A multicenter phase 2 study dlvr.it/TWMftM
How far are we from multi-omics states to therapeutic targets in microsatellite-stable colorectal cancer? dlvr.it/TWKNR5
Antibiotics and outcomes of cancer immunotherapy: An updated meta-analysis and clinical applications dlvr.it/TWJd4t
KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer dlvr.it/TWJQy6
Multiomic characterization of microsatellite-stable colorectal cancer reveals distinct biology and targetable vulnerabilities dlvr.it/TWHyqW
Firmonertinib in advanced non-small cell lung cancer with epidermal growth factor receptor P-loop and αC-helix compressing mutations dlvr.it/TWHrFb
Decoding neutrophil spatial heterogeneity and clinical implications in breast cancer dlvr.it/TWHfk3
A stroma-sensing TGF-β blockade reprograms CAF-myeloid niches to induce durable tumor immunity dlvr.it/TWHBk9
Chromatin accessibility trajectories reveal pre-cancerous epigenetic priming and an acid-driven immunotherapy-resistant gastric cancer subtype dlvr.it/TWGsF1




















